We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




USP15 Promotes Brain Cancer by Activating the TGF-beta Pathway

By LabMedica International staff writers
Posted on 07 Mar 2012
Print article
The USP15 protein has been identified as a potential therapeutic target that may accelerate drug development against glioblastoma and certain other types of cancer.

Investigators at the Vall d'Hebron Institute of Oncology (Barcelona, Spain) reported in the February 19, 2012, online edition of the journal Nature Medicine that they had identified the de-ubiquitinating enzyme ubiquitin-specific peptidase 15 (USP15) as a key component of the TGF-beta signaling pathway, and that USP15 promoted tumor progression by activating the TGF-beta pathway.

The TGF-beta pathway controls proliferation, cellular differentiation, and other functions in most cells. It plays a role in immunity, cancer, heart disease, and diabetes. TGF-beta acts as an antiproliferative factor in normal epithelial cells and at early stages of cancer development. In normal cells, TGF-beta, acting through its signaling pathway, stops the cell cycle at the G1 stage to stop proliferation, induce differentiation, or promote apoptosis. When a cell is transformed into a cancer cell, parts of the TGF-beta signaling pathway are mutated, and TGF-beta no longer controls the cell. These cancer cells and surrounding stromal cells (fibroblasts) begin to proliferate. Both types of cell increase their production of TGF-beta. This TGF-beta acts on the surrounding stromal cells, immune cells, endothelial, and smooth muscle cells. It causes immunosuppression and angiogenesis, which makes the cancer more invasive. TGF-beta also converts effector T-cells, which normally attack cancer with an inflammatory reaction, into regulatory (suppressor) T-cells, which turn off the inflammatory reaction.

USP15 was also found to stabilize type I TGF-beta receptor (TbetaR-I), leading to an enhanced TGF-beta signal. High expression of USP15 correlated with high TGF-beta activity, and the USP15 gene was found to be amplified in glioblastoma, breast, and ovarian cancer. USP15 amplification conferred poor prognosis in individuals with glioblastoma.

The important role of USP15 was confirmed by the finding that downregulation or inhibition of USP15 in a patient-derived mouse model of glioblastoma decreased TGF-beta activity. Moreover, depletion of USP15 decreased the oncogenic capacity of patient-derived glioma-initiating cells due to the repression of TGF-beta signaling.

Senior author Dr. Joan Seoane, director of translational research at the Vall d'Hebron Institute of Oncology, said, “When we inhibited USP15 in a real model of human glioblastoma, TGF-beta activity decreased and the tumor did not develop. USP15 regulates tumor progression and is critical in cancer.”

Related Links:
Vall d'Hebron Institute of Oncology


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Urine Collection Container
Urine Monovette
New
LH ELISA
Luteinizing Hormone ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.